May 3, 2005 — The U.S. Food and Drug Administration has approved first-time generic formulations of niacin extended-release 500-, 750-, and 1,000-mg tablets for the treatment of hypercholesterolemia; ...

Allegan-based Perrigo Co. (Nasdaq: PRGO) Tuesday announced that it has acquired the exclusive United States store brand rights to sell and distribute over-the-counter versions of Fexofenadine HCl 180 ...

HYDERABAD, India — The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said. Dr. Reddy's ...

Buys rights to OTC version of generic Allegra from Teva Deal terms not disclosed Allegra is Sanofi's allergy drug June 29 (Reuters) - Generic drugmaker Perrigo Co said it bought the U.S. store brand ...

BOSTON (MarketWatch) -- Sanofi-Aventis and partner Albany Molecular Research filed a motion in federal court Wednesday to prevent several drug makers from marketing generic versions of top-selling ...

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New ...

WASHINGTON, Nov 8 (Reuters) - A U.S. appeals court upheld on Wednesday a ruling allowing generic drug makers to continue selling versions of Sanofi-Aventis' popular allergy drug Allegra while Sanofi ...

- Settlement and License Agreement for Generic Versions of Nasacort(R) AQ - Settlement and License Agreement with Aventis and Albany Molecular Research, Inc. for Generic Versions of Allegra(R) D-12 - ...

The company will be entitled to 180 days of marketing exclusivity on the products.Barr Pharmaceuticals (NYSE: BRL) announced Thursday that Barr Laboratories has received final approval from the U.S.

NEW YORK - Barr Pharmaceuticals Inc said today it sued the U.S. Food and Drug Administration, seeking to ensure exclusive rights to sell a generic version of Sanofi-Aventis' popular Allegra-D allergy ...

Two generic-drug makers joined forces to launch a copycat version of Sanofi-Aventis SA's third-biggest drug, the allergy medicine Allegra, much earlier than many investors expected. The launch is a ...

First-Time Generic Approvals: Nydrazid, Aclovate, Allegra The FDA has approved first-time generic formulations of isoniazid 100-mg/mL injection, USP, in 10-mL multiple-dose vials (Nydrazid), ...